A licensed rights position
Clinical workflow, device data, payer automation, or retail systems claims licensed into the venture, with the field of use written down.
Intellectual Frontiers Studios
Intellectual Frontiers Studios starts companies around licensed patents and findings that already survived contact with real hospital, device, trial site, insurance, and marketplace operations, then runs them until they can stand alone.
We charter a venture when we hold a rights position, somebody has already paid for something adjacent, and an operator who knows the market is willing to own the outcome. Nobody starts a payer-operations company because payer operations look big.
Paid work beats pilots. A hospital that put a purchase order against an operating budget line has told us more than ten that signed a letter of intent, and a research site paying monthly tells us more than a free vendor pilot. Ventures that cannot earn revenue against a real budget line get closed early and cheaply.
The ventures worth chartering do work nobody was staffed to do. A company that reads every denial a plan issues the day it lands, or one that keeps a device submission's evidence assembled while the product runs, is doing a job that did not exist to be automated. That is a harder company to start and a much harder one to displace.
A company that starts above zero, because the hard parts are already in place before the first hire.
Clinical workflow, device data, payer automation, or retail systems claims licensed into the venture, with the field of use written down.
People who have carried an FDA submission, an insurance integration, a trials platform rollout, or a large system replacement to the finish.
Our research relationships are where most ventures find their first paying customer, rather than starting cold.
Entity, cap table, closure condition, and independence plan are set at the charter and held to when the venture gets uncomfortable.
Healthcare delivery, where the problem is usually getting outside data into a clinician's hands without another interface project. Medical devices, where the software organization decides whether the hardware ships on time. Insurance and digital authorization, where who may read what, and the proof it happened, consume operations budgets. Clinical trials, where the study still runs on binders and reconciliation. Digital marketplaces and payments, where many parties have to settle and keep the evidence.
Each of those is a market we have worked in. We do not charter ventures in markets nobody here has operated.
Operators bring a market they have run and a problem they know is worth paying for. Health systems, manufacturers, insurers, and research organizations bring an internal project that should be a company but will never get funded inside. Investors bring capital alongside Intellectual Frontiers Capital once a venture has contracted revenue.
Come prepared to say what has already been paid for, what right the venture would need, and who would own the outcome.
These pages show the standard a proposal is measured against.
Every venture and shared service we have chartered, including the ones we closed.
Deployments we have run in provider, device, trials, insurance, and marketplace settings.
Rights positions available to license into a new company.
How we size a market before committing people to it.
Send the market, the paying buyer, and the operator who would run it.